Skip to main content
. 2018 Jun 4;15(9):892–899. doi: 10.7150/ijms.24042

Figure 2.

Figure 2

(A) The proportion of CD8Ts in recipients as function of age. (B) The proportion of CD8Ts in patients in >10, 5-10, and 0-5 ng/ml tacrolimus groups. (C, D) Proportion of CD8Ts in patients during the first year after LT (C) and at later time points (D).